Standard of Care the Safety and Efficacy of Cilta-cel for RRMM Patients Multiple Myeloma 3 Mins Read3 In this study, the researchers evaluated the use of standard of care (SOC) ciltacabtagene autoleucel in a patient population and…
2023 ASH Multiple Myeloma Updates [Slides] – Lisa Lee, MD MOASC Multiple Myeloma 16 Mins Read3 2023 ASH BCMA & Multiple Myeloma Updates with Slides by: Lisa Lee, MD – Assistant Professor — Division of Hematology-Oncology, Department…
